Search results
Author(s):
Gregg Stone
,
Harriette Van Spall
Added:
2 years ago
Dr Gregg W Stone (Mount Sinai Heart Health System, New York, US) and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the latest results from the ISCHEMIA trial.
The trial assessed the impact of completeness of revascularization on clinical outcomes in patients with stable ischemic heart disease treated with an invasive versus conservative strategy.
Recorded remotely from New…
View more
Author(s):
Mirvat Alasnag
Added:
10 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary…
View more
Author(s):
Matthias Gotberg
Added:
2 years ago
In this short summary interview, Dr Matthias Götberg (Lund University, Lund, SE) discusses the five-year outcomes of a randomized trial of iFR-guided vs FFR-guided PCI (FR-SWEDEHEART). The study, presented at TCT 2021, demonstrated that the 5-year results of iFR-SWEDEHEART showed no difference in outcome at 5-years compared with FFR.
Discussion Points:
Importance of the study
Study design and…
View more
Transesophageal Echocardiography
Author(s):
Bijoy K Khandheria
Added:
3 years ago
Article
Author(s):
George A Beller
Added:
3 years ago
A significant amount of data has accumulated over the past 20 years, demonstrating the value of exercise or pharmacologic stress non-invasive cardiovascular imaging techniques for the diagnostic and prognostic assessment of patients with suspected or known cardiovascular disease.1-8 Stress can be induced by either multistage exercise testing that is symptom-limited or by pharmacologic means with…
View more
Author(s):
Leah A John
,
Ahmadreza Karimianpour
,
Michael R Gold
Added:
2 years ago
Author(s):
David Berg
Added:
1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834).
This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study…
View more
Added:
1 year ago
TCT 22 - Prof Helge Möllmann joins us to discuss the findings of a study that aimed to evaluate the procedural safety and device performance of Abbott's Portico™ TAVI Valve in patients with severe symptomatic degenerative aortic stenosis.
Originally presented at TCT 22, The CONFIDENCE Registry involved over 1000 patients with NYHA Class ≥ II Aortic Stenosis who received transcatheter aortic…
View more
Author(s):
Oussama M Wazni
,
Andrea Natale
Added:
3 years ago
Atrial fibrillation (AF) affects approximately two million people in the US. It is a major cause of stroke, adversely impacts quality of life, and is associated with increased mortality.1-4 Treatment with antiarrhythmic drugs and anticoagulation is still considered first-line therapy in patients with symptomatic AF.
Recent randomized trials4,5 have shown that a strategy of rate control and…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
7 months ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the third day of ESC Congress 2023.
New data releases covered in detail include:
ILUMIEN IV
OCTIVUS
OCTOBER
OCT Vs IVUS Vs Angiography Guidance Meta-analysis
MULTISTARS-AMI
ATTRibute
Recorded on-site at ESC Congress 2023, Amsterdam.
Editors: Mirjam Boros…
View more